| Model Number |
FHC-202 |
| Medical Device Problem Code |
False Positive Result (1227)
|
| Health Effect - Clinical Code |
No Consequences Or Impact To Patient (2199)
|
| Date of Event |
05/23/2019
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
At the time of the event, there was no indication of a reportable malfunction based on information provided and assessed by alere (b)(4).Alere (b)(4) updated reporting decisions and conducted a retrospective review of complaints against the updated reporting decisions.This mdr is a retrospective filing that was identified during this retrospective review activity associated with an observation from an fda inspection conducted in january 2019 at alere (b)(4) (reference eir (b)(4)).The awareness date is based on updated reporting decisions and completion of the retrospective review activity.There is no new or increased trend based on this retrospective review activity.Investigation results an investigation was performed on retention products for the reported lot number.Retention devices were tested with clinical hcg-negative urine samples.Results were read at 3 minutes and all devices produced expected negative results.No faint test lines were observed.Manufacturing batch record review did not uncover any abnormalities and the lot met quality control specifications.A root cause could not be determined from the available information.It was reported that 4 drops of sample were added to the sample well.Per the pi, 3 drops of urine or serum should be added to the sample well.This test provides a presumptive diagnosis for pregnancy.A confirmed pregnancy diagnosis should only be made by a physician after all clinical and laboratory findings have been evaluated.
|
| |
|
Event or Problem Description
|
|
It was reported by a customer that on (b)(6) 2018, a female patient was tested as a screening procedure used by a study conducted by a university.The customer stated the entity administered an hcg serum/urine test and a false positive result occurred twice.In order to be eligible for the study, the patients cannot be pregnant as they will undergo an elective mri (magnetic resonance imaging) procedure.The patient sample was tested four times resulting in two positive results followed by two negative results.The first and second test showed a light line on the test region which was interpreted as positive.The third and fourth test results were a clear negative.The customer confirmed that not being eligible for the study did not affect the patient health, no adverse outcomes experienced.The confirmatory results are confidential, a different group of the study performs confirmatory testing.
|
| |
|
Search Alerts/Recalls
|